Literature DB >> 25024607

High fat diet feeding results in gender specific steatohepatitis and inflammasome activation.

Michal Ganz1, Timea Csak1, Gyongyi Szabo1.   

Abstract

AIM: To develop an animal model that encompasses the different facets of non-alcoholic steatohepatitis (NASH), which has been a challenge.
METHODS: In this study, we used a high fat diet (HFD) feeding supplemented with fructose and sucrose in the water mimicking the high-fructose corn syrup that is abundant in the diet in the United States. We used C57Bl/6 wild-type mice for short and long-term feedings of 6 and 16 wk respectively, and evaluated the extent of liver damage, steatosis, and inflammasome activation. Our methods included histopathological analysis to assess liver damage and steatosis, which involved H and E and oil-red-o staining; biochemical studies to look at ALT and triglyceride levels; RNA analysis using quantitative polymerase chain reaction; and cytokine analysis, which included the enzyme-linked immunosorbent assay method to look at interleukin (IL)-1β and tumor necrosis factor-α (TNFα) levels. Furthermore, at each length of feeding we also looked at insulin resistance and glucose tolerance using insulin tolerance tests (ITT) and glucose tolerance tests.
RESULTS: There was no insulin resistance, steatosis, or inflammasome activation at 6 wk. In contrast, at 16 wk we found significant insulin resistance demonstrated by impaired glucose and ITT in male, but not female mice. In males, elevated alanine aminotransferase and triglyceride levels, indicated liver damage and steatosis, respectively. Increased liver TNFα and monocyte chemoattractant protein-1 mRNA and protein, correlated with steatohepatitis. The inflammasome components, adaptor molecule, Aim2, and NOD-like receptor 4, increased at the mRNA level, and functional inflammasome activation was indicated by increased caspase-1 activity and IL-1β protein levels in male mice fed a long-term HFD. Male mice on HFD had increased α-smooth muscle actin and pro-collagen-1 mRNA indicating evolving fibrosis. In contrast, female mice displayed only elevated triglyceride levels, steatosis, and no fibrosis.
CONCLUSION: Our data indicate gender differences in NASH. Male mice fed a long-term HFD display steatohepatitis and inflammasome activation, whereas female mice have steatosis without inflammation.

Entities:  

Keywords:  Gender differences; High fat diet; Inflammasome; Non-alcoholic steatohepatitis

Mesh:

Substances:

Year:  2014        PMID: 25024607      PMCID: PMC4093702          DOI: 10.3748/wjg.v20.i26.8525

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  37 in total

Review 1.  The inflammasome in pathogen recognition and inflammation.

Authors:  Fayyaz S Sutterwala; Yasunori Ogura; Richard A Flavell
Journal:  J Leukoc Biol       Date:  2007-04-30       Impact factor: 4.962

2.  Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells.

Authors:  Timea Csak; Michal Ganz; Justin Pespisa; Karen Kodys; Angela Dolganiuc; Gyongyi Szabo
Journal:  Hepatology       Date:  2011-07       Impact factor: 17.425

3.  Critical role of toll-like receptors and the common TLR adaptor, MyD88, in induction of granulomas and liver injury.

Authors:  Arumugam Velayudham; Istvan Hritz; Angela Dolganiuc; Pranoti Mandrekar; Evelyn Kurt-Jones; Gyongyi Szabo
Journal:  J Hepatol       Date:  2006-07-31       Impact factor: 25.083

4.  Mitochondrial antiviral signaling protein defect links impaired antiviral response and liver injury in steatohepatitis in mice.

Authors:  Timea Csak; Angela Dolganiuc; Karen Kodys; Bharath Nath; Jan Petrasek; Shashi Bala; Dora Lippai; Gyongyi Szabo
Journal:  Hepatology       Date:  2011-05-02       Impact factor: 17.425

5.  Inflammasome is a central player in the induction of obesity and insulin resistance.

Authors:  Rinke Stienstra; Janna A van Diepen; Cees J Tack; Md Hasan Zaki; Frank L van de Veerdonk; Deshani Perera; Geoffrey A Neale; Guido J Hooiveld; Anneke Hijmans; Irene Vroegrijk; Sjoerd van den Berg; Johannes Romijn; Patrick C N Rensen; Leo A B Joosten; Mihai G Netea; Thirumala-Devi Kanneganti
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-29       Impact factor: 11.205

Review 6.  Primary liver cancer: worldwide incidence and trends.

Authors:  F Xavier Bosch; Josepa Ribes; Mireia Díaz; Ramon Cléries
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

Review 7.  Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.

Authors:  Yoshihisa Takahashi; Yurie Soejima; Toshio Fukusato
Journal:  World J Gastroenterol       Date:  2012-05-21       Impact factor: 5.742

Review 8.  Control of innate and adaptive immunity by the inflammasome.

Authors:  Ceren Ciraci; John R Janczy; Fayyaz S Sutterwala; Suzanne L Cassel
Journal:  Microbes Infect       Date:  2012-07-24       Impact factor: 2.700

9.  Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production.

Authors:  Willscott E Naugler; Toshiharu Sakurai; Sunhwa Kim; Shin Maeda; Kyounghyun Kim; Ahmed M Elsharkawy; Michael Karin
Journal:  Science       Date:  2007-07-06       Impact factor: 47.728

10.  Characterization of high-fat, diet-induced, non-alcoholic steatohepatitis with fibrosis in rats.

Authors:  Zheng-Jie Xu; Jian-Gao Fan; Xiao-Dong Ding; Liang Qiao; Guo-Liang Wang
Journal:  Dig Dis Sci       Date:  2009-05-21       Impact factor: 3.199

View more
  39 in total

1.  Sex modifies the consequences of extended fructose consumption on liver health, motor function, and physiological damage in rats.

Authors:  Molly M Hyer; Samya K Dyer; Alix Kloster; Anum Adrees; Thomas Taetzsch; Jonathan Feaster; Gregorio Valdez; Gretchen N Neigh
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-09-25       Impact factor: 3.619

Review 2.  Innate immune signaling and gut-liver interactions in non-alcoholic fatty liver disease.

Authors:  Veerle Bieghs; Christian Trautwein
Journal:  Hepatobiliary Surg Nutr       Date:  2014-12       Impact factor: 7.293

Review 3.  Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps.

Authors:  Amedeo Lonardo; Fabio Nascimbeni; Stefano Ballestri; DeLisa Fairweather; Sanda Win; Tin A Than; Manal F Abdelmalek; Ayako Suzuki
Journal:  Hepatology       Date:  2019-09-23       Impact factor: 17.425

4.  High Fat Diet Feeding and High Throughput Triacylglyceride Assay in Drosophila Melanogaster.

Authors:  Soda Balla Diop; Ryan T Birse; Rolf Bodmer
Journal:  J Vis Exp       Date:  2017-09-13       Impact factor: 1.355

Review 5.  Inflammasome activation and function in liver disease.

Authors:  Gyongyi Szabo; Jan Petrasek
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-06-09       Impact factor: 46.802

6.  Clopidogrel Resistance in a Murine Model of Diet-Induced Obesity Is Mediated by the Interleukin-1 Receptor and Overcome With DT-678.

Authors:  Yifang Sun; Jessica Venugopal; Chiao Guo; Yanbo Fan; Jianping Li; Yanjun Gong; Y Eugene Chen; Haoming Zhang; Daniel T Eitzman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-04-09       Impact factor: 8.311

7.  Deficiency of intestinal mucin-2 protects mice from diet-induced fatty liver disease and obesity.

Authors:  Phillipp Hartmann; Caroline T Seebauer; Magdalena Mazagova; Angela Horvath; Lirui Wang; Cristina Llorente; Nissi M Varki; Katharina Brandl; Samuel B Ho; Bernd Schnabl
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-12-23       Impact factor: 4.052

Review 8.  Sex differences in obesity-induced hypertension and vascular dysfunction: a protective role for estrogen in adipose tissue inflammation?

Authors:  Lia E Taylor; Jennifer C Sullivan
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-08-10       Impact factor: 3.619

9.  NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice.

Authors:  Auvro R Mridha; Alexander Wree; Avril A B Robertson; Matthew M Yeh; Casey D Johnson; Derrick M Van Rooyen; Fahrettin Haczeyni; Narci C-H Teoh; Christopher Savard; George N Ioannou; Seth L Masters; Kate Schroder; Matthew A Cooper; Ariel E Feldstein; Geoffrey C Farrell
Journal:  J Hepatol       Date:  2017-02-03       Impact factor: 25.083

Review 10.  Experimental models of liver fibrosis.

Authors:  Sara Crespo Yanguas; Bruno Cogliati; Joost Willebrords; Michaël Maes; Isabelle Colle; Bert van den Bossche; Claudia Pinto Marques Souza de Oliveira; Wellington Andraus; Venâncio Avancini Ferreira Alves; Isabelle Leclercq; Mathieu Vinken
Journal:  Arch Toxicol       Date:  2015-06-06       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.